<DOC>
	<DOCNO>NCT02497222</DOCNO>
	<brief_summary>This study evaluate use RNS60 treatment asthma examine regional improvement inflammation use PET image . All subject treat RNS60 placebo crossover design .</brief_summary>
	<brief_title>Pilot Study RNS60 Allergen-induced Bronchoconstriction</brief_title>
	<detailed_description />
	<criteria>Males female mild asthma ( defined National Institutes Health 2002 Guidelines Diagnosis Management Asthma ( 2 ) ) symptoms 2 time week less per day normal FEV1 ( &gt; 80 % predict ) . Clinical history allergic symptom cat dust mite allergen demonstrate skin reactivity . Subjects must lifetime total less 5 pack year smoke previous 5 year . Willing able give inform consent adhere study protocol requirement . Expressed desire participate study interview principal investigator ( PI ) . Age 18 50 year . Women childbearing potential document pregnant ( base blood betahuman chorionic gonadotropin [ HCG ] test ) nursing . The presence spontaneous asthmatic episode clinical evidence upper respiratory tract infection within previous 6 week . Participation research study involve drug biologic 30 day prior study . Intolerance albuterol , atropine , lidocaine . Antihistamines within 7 day screen visit . Known exposure agent associate pulmonary disease ( i.e . asbestos , silica ) . Presence known pulmonary disease , coronary disease , congestive heart failure , ventricular arrhythmia , history cerebrovascular accident , renal failure ( creatinine &gt; 1.5 , know ) , history anaphylaxis , cirrhosis , diabetes mellitus presence significant disease , opinion PI would pose significant risk subject confound result study . Use systemic steroid , increase use inhaled steroid , use beta blocker monoamine oxidase ( MAO ) inhibitor visit asthma exacerbation within 1 month screen visit . A history asthmarelated respiratory failure require intubation . A history hospitalization asthma . Subjects high possibility poor compliance study judge PI . Unresponsive bronchodilator agent . Quantitative skin prick test dilution level standardize cat allergen extract 1:2048 ( 4.88 BAU/ml ) subject challenged cat allergen . Quantitative skin prick test dilution level standardize mite allergen extract 1:2048 ( 4.88 AU/ml ) subject challenge either mite allergen . Subjects , participate research study , cumulative radiation dose exceed 50 mSv previous year . Contraindication Methacholine challenge test ( heart attack stroke last 3 month , uncontrolled hypertension , know aortic aneurysm ) . Body Mass Index ( BMI ) &gt; 32 . Individuals know allergy hypersensitivity FDG exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>